b) Subject to the terms and conditions of this Agreement, the Company shall sell, and the Investors shall purchase, an aggregate of 642,583 shares of Series B Preferred Stock (the "Preferred Shares"). Each Investor agrees severally to purchase, and...Registration Rights Agreement • November 14th, 1995 • Oxis International Inc • Pharmaceutical preparations • Delaware
